08 December 2020 2 Min Read
FDA gives early safety assurance on Pfizer-BioNTech vaccine data
The vaccine’s efficacy data met expectations for emergency use authorisation, but it has yet to be decided if it is suitable for people aged over 16
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In